Pheniramine Maleate and Naphazoline Hydrochloride

CHEBI:CHEBI_747911

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1046266
marketing_category
NDA
listing_expiration_date
20251231
product_type
HUMAN OTC DRUG
dosage_form
SOLUTION/ DROPS
active_ingredient_strength
3.15 mg/mL
route
OPHTHALMIC
labeler_name
DOLGENCORP, LLC
manufacturer_name
DOLGENCORP, LLC
active_ingredient_name
PHENIRAMINE MALEATE
unii
NYW905655B
marketing_start_date
20150701
package_marketing_start_date
19950103
generic_name
naphazoline hydrochloride and pheniramine maleate
brand_name
Naphcon A
brand_name_base
Naphcon A
product_ndc
11822-0552
application_number
NDA020226
spl_id
1ddd20f0-11d5-dbe0-e063-6394a90ada1f
package_ndc
11822-0552-2
package_description
2 BOTTLE, DROPPER in 1 CARTON (11822-0552-2) / 15 mL in 1 BOTTLE, DROPPER
spl_set_id
6043040e-3206-40dd-aa87-940b1a84a496
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class